These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32241691)

  • 1. Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer.
    Eichenauer T; Simmendinger L; Kluth M; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Büscheck F; Bernreuther C; Clauditz T; Lebok P; Simon R; Sauter G; Wilczak W; Fraune C
    Urol Oncol; 2020 Jun; 38(6):605.e1-605.e8. PubMed ID: 32241691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival.
    Eichenauer T; Bannenberg DC; Kluth M; Wittmer C; Büscheck F; Möller K; Dum D; Fraune C; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz TS
    Urol Oncol; 2020 Feb; 38(2):43.e13-43.e20. PubMed ID: 31757738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
    Eichenauer T; Shadanpour N; Kluth M; Göbel C; Weidemann S; Fraune C; Büscheck F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Burandt E; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz T
    World J Surg Oncol; 2020 Jun; 18(1):128. PubMed ID: 32534597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
    de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
    Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
    La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
    Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
    El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
    Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
    El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
    Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between chromosome 9p21 locus deletion and prognosis in clinically localized prostate cancer.
    Barros ÉAF; Pontes-Junior J; Reis ST; Lima AER; Souza IC; Salgueiro JL; Fontes D; Dellê H; Coelho RF; Viana NI; Leite KRM; Nahas WC; Srougi M
    Int J Biol Markers; 2017 May; 32(2):e248-e254. PubMed ID: 28058701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma.
    Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G
    Mod Pathol; 2008 Jan; 21(1):1-6. PubMed ID: 17906617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.
    Schraml P; Struckmann K; Bednar R; Fu W; Gasser T; Wilber K; Kononen J; Sauter G; Mihatsch MJ; Moch H
    Am J Pathol; 2001 Feb; 158(2):593-601. PubMed ID: 11159196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
    Schraml P; Müller D; Bednar R; Gasser T; Sauter G; Mihatsch MJ; Moch H
    J Pathol; 2000 Mar; 190(4):457-61. PubMed ID: 10699995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.
    Lebok P; Roming M; Kluth M; Koop C; Özden C; Taskin B; Hussein K; Lebeau A; Witzel I; Wölber L; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Müller V; Schmalfeldt B; Simon R; Sauter G; Terracciano L; Krech RH; von der Assen A; Burandt E
    Oncotarget; 2016 Dec; 7(49):81322-81331. PubMed ID: 27835607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of 9p21 Regulatory Hub Promotes Kidney Cancer Progression by Upregulating HOXB13.
    Baietti MF; Zhao P; Crowther J; Sewduth RN; De Troyer L; Debiec-Rychter M; Sablina AA
    Mol Cancer Res; 2021 Jun; 19(6):979-990. PubMed ID: 33619226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
    Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
    J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
    Büscheck F; Fraune C; Kluth M; Lennartz M; Simon R; Hube-Magg C; Morlock C; Barbieri S; Wahl C; Eichelberg C; Möller-Koop C; Höflmayer D; Wittmer C; Wilczak W; Sauter G; Fisch M; Eichenauer T; Rink M
    World J Urol; 2021 Mar; 39(3):829-837. PubMed ID: 32361874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.
    El-Mokadem I; Lim A; Kidd T; Garret K; Pratt N; Batty D; Fleming S; Nabi G
    BMC Cancer; 2016 Jul; 16():546. PubMed ID: 27465101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8p deletion is strongly linked to poor prognosis in breast cancer.
    Lebok P; Mittenzwei A; Kluth M; Özden C; Taskin B; Hussein K; Möller K; Hartmann A; Lebeau A; Witzel I; Mahner S; Wölber L; Jänicke F; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Terracciano L; Krech R; von der Assen A; Müller V; Burandt E
    Cancer Biol Ther; 2015; 16(7):1080-7. PubMed ID: 25961141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.
    Nejati R; Wei S; Uzzo RG; Poureghbali S; Pei J; Talarchek JN; Ruth K; Dulaimi E; Kutikov A; Testa JR; Al-Saleem T
    Clin Genitourin Cancer; 2020 Feb; 18(1):56-61. PubMed ID: 31648964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.